ketanserin has been researched along with Hemolysis, Elevated Liver Enzymes, Lowered Platelets in 4 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ketanserin is an attractive alternative in the management of severe early-onset preeclampsia." | 6.69 | Ketanserin versus dihydralazine in the management of severe early-onset preeclampsia: maternal outcome. ( Bolte, AC; Bruinse, HW; Dekker, GA; Kanhai, HH; van Eyck, J; van Geijn, HP, 1999) |
| "Ketanserin appears to be a better option than dihydralazine for treatment of severe preeclampsia since fewer maternal complications and side-effects were observed in patients receiving ketanserin." | 5.31 | Ketanserin for the treatment of preeclampsia. ( Bolte, AC; Dekker, GA; Gaffar, SF; van Eyck, J; van Geijn, HP, 2001) |
| "Ketanserin is an attractive alternative in the management of severe early-onset preeclampsia." | 2.69 | Ketanserin versus dihydralazine in the management of severe early-onset preeclampsia: maternal outcome. ( Bolte, AC; Bruinse, HW; Dekker, GA; Kanhai, HH; van Eyck, J; van Geijn, HP, 1999) |
| " Non-parametric as well as parametric tests were used to analyze the effect of gestational age, birth weight, gender, various ketanserin factors (cumulative dosage, duration of therapy and last dosage rate), other maternal drug use and maternal diagnosis on the blood pressure of the neonate." | 1.38 | The effect of maternal ketanserin use on the circulation of the neonate: a prospective, observational study. ( de Vries, NK; Morssink, LP; Schaafstra, L; van Roon, EN, 2012) |
| "Ketanserin appears to be a better option than dihydralazine for treatment of severe preeclampsia since fewer maternal complications and side-effects were observed in patients receiving ketanserin." | 1.31 | Ketanserin for the treatment of preeclampsia. ( Bolte, AC; Dekker, GA; Gaffar, SF; van Eyck, J; van Geijn, HP, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schaafstra, L | 1 |
| van Roon, EN | 1 |
| Morssink, LP | 1 |
| de Vries, NK | 1 |
| Banga, FR | 1 |
| Bolte, AC | 3 |
| Dekker, GA | 3 |
| van Geijn, HP | 3 |
| van Eyck, J | 2 |
| Kanhai, HH | 1 |
| Bruinse, HW | 1 |
| Gaffar, SF | 1 |
1 trial available for ketanserin and Hemolysis, Elevated Liver Enzymes, Lowered Platelets
| Article | Year |
|---|---|
Ketanserin versus dihydralazine in the management of severe early-onset preeclampsia: maternal outcome.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Dihydralazine; Female; HELLP Syndrome; Humans; Ketan | 1999 |
3 other studies available for ketanserin and Hemolysis, Elevated Liver Enzymes, Lowered Platelets
| Article | Year |
|---|---|
The effect of maternal ketanserin use on the circulation of the neonate: a prospective, observational study.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Female; Heart Rate; HELLP Syndrome; Humans; Infant, | 2012 |
Ketanserin in women with chronic hypertension and underlying thrombophilia.
Topics: Adult; Antihypertensive Agents; Female; Fetal Growth Retardation; HELLP Syndrome; Humans; Hypertensi | 2004 |
Ketanserin for the treatment of preeclampsia.
Topics: Antihypertensive Agents; Aspartate Aminotransferases; Delivery, Obstetric; Dihydralazine; Female; Ge | 2001 |